No definition available.
Gestational [pregnancy-induced] oedema and proteinuria without hypertension
EFO MESH Endpoint Browser PheWeb
O15_GESTAT_OEDEM_PREINUR
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3609 |
4. Check minimum number of eventsNone |
3609 |
5. Include endpointsNone |
3609 |
6. Filter based on genotype QC (FinnGen only) |
3609 |
Control definitions (FinnGen only)
- Control exclude
- O15_OEDEM_PROTUR_HYPERT
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
- Parent code in ICD-10
- O10-O16
- Name in latin
- Oedema et proteinuria gravidarum sine hypertensione
Similar endpoints
↥List of similar endpoints to
Gestational [pregnancy-induced] oedema and proteinuria without hypertension
based on the number of shared cases.
Similar with more cases:
- Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium
- Pregnancy, childbirth and the puerperium
- Any event in hilmo or specialist outpatient
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 26938 | 26938 | - |
| Only index persons | 25995 | 25995 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.77 | 0.77 | - |
| Only index persons | 0.96 | 0.96 | - |
| Median age at first event (years) | |||
| Whole population | - | 27.57 | - |
| Only index persons | - | 27.52 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3609 | 3609 | - |
| Unadjusted period prevalence (%) | 1.23 | 1.23 | - |
| Median age at first event (years) | 27.66 | 27.66 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3285
- Matched controls
- 32850
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
63700
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Albuminuria (proteinuria)
+∞
323.0
840
*
O13
ICD-10 Finland
Gestational [pregnancy-induced] hypertension
1464.5
323.0
388
*
63702
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Oedema
+∞
323.0
852
*
O12.1
ICD-10 Finland
Gestational proteinuria
8748.3
323.0
704
*
O12.0
ICD-10 Finland
Gestational oedema
1479.0
323.0
502
*
6462A
ICD-9 Finland
Other complications of pregnancy, not elsewhere classified, Unspecified renal disease in pregnancy, without mention of hypertension
+∞
246.0
233
*
O14.0
ICD-10 Finland
Mild to moderate pre-eclampsia
+∞
224.6
213
*
63701
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Hypertonia
+∞
171.4
163
*
6461A
ICD-9 Finland
Other complications of pregnancy, not elsewhere classified, Oedema or excessive weight gain in pregnancy, without mention of hypertension
+∞
149.1
142
*
O14.9
ICD-10 Finland
Pre-eclampsia, unspecified
481.2
140.4
139
*
O12.2
ICD-10 Finland
Gestational oedema with proteinuria
+∞
137.5
131
*
63703
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia levis
+∞
131.1
125
*
O10.0
ICD-10 Finland
Pre-existing essential hypertension complicating pregnancy, childbirth and the puerperium
+∞
85.8
82
*
O14.1
ICD-10 Finland
Severe pre-eclampsia
+∞
70.0
67
*
6424A
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, ENNEN SYNNYTYSTÄ]
+∞
65.8
63
*
E66.01
ICD-10 Finland
Obesity due to excess calories
2.9
58.2
399
1512
MA2AE
NOMESCO Finland
Ultrasound examination of pregnancy (at 12. week of gestaion or later) including basic examination of fetus
2.1
49.7
652
3444
Z35.8
ICD-10 Finland
Supervision of other high-risk pregnancies
2.5
47.1
419
1835
205
Kela drug reimbursment
Chronic hypertension
2.1
45.3
630
3394
65000
ICD-8 Finland
Delivery without mention of complication, Occipital presentation
1.7
45.2
1342
9403
O24.4
ICD-10 Finland
Diabetes mellitus arising in pregnancy
2.5
43.7
392
1720
6423A
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Transient hypertension of pregnancy[HYPERTENSIO GRAVIDARUM, ENNEN SYNNYTYSTÄ]
+∞
42.8
41
*
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
2.2
42.3
461
2226
103
Kela drug reimbursment
Diabetes, insulin-treated
2.0
41.5
651
3666
215
Kela drug reimbursment
Diabetes, non-insulin-treated
2.0
41.4
640
3585
Y6099
ICD-8 Finland
Prenatal care and observation
2.7
39.6
296
1173
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
37.0
1435
10639
O24.0
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, insulin-dependent
5.8
36.4
106
188
Z36.3
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
1.7
35.9
898
5877
O36.6
ICD-10 Finland
Maternal care for excessive fetal growth
3.3
35.4
187
588
A10BA02
ATC
metformin; oral
1.8
34.7
669
4023
MA2DE
NOMESCO Finland
Detailed ultrasound examination of fetus including color doppler method
2.2
33.5
356
1689
O82.10
ICD-10 Finland
Delivery by emergency caesarean section
2.5
32.3
264
1096
C09AA02
ATC
enalapril; systemic
2.0
32.2
462
2491
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.9
31.4
518
2940
40199
ICD-8 Finland
Essential benign hypertension
8.4
30.9
69
84
C03CA01
ATC
furosemide; systemic
1.8
30.5
597
3591
E66.8
ICD-10 Finland
Other obesity
2.6
30.5
228
901
T90
ICPC
Diabetes non-insulin dependent
1.8
29.9
562
3336
O80.8
ICD-10 Finland
Other single spontaneous delivery
2.8
29.2
203
768
6420X
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Benign essential hypertension complicating pregnancy, childbirth and the puerperium
+∞
29.2
28
*
R80
ICD-10 Finland
Isolated proteinuria
9.8
28.6
58
60
63704
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia gravis
+∞
28.2
27
*
MA2HE
NOMESCO Finland
Detailed morfological ultrasound examination of fetus
1.8
28.1
601
3710
C07AG01
ATC
labetalol; systemic
12.7
28.0
50
40
W84
ICPC
Pregnancy high risk
3.1
27.9
160
534
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
27.3
1309
9973
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.6
27.2
205
814
A10AE04
ATC
insulin glargine; parenteral
2.4
26.7
235
1013
O47.0
ICD-10 Finland
False labour before 37 completed weeks of gestation
2.0
26.6
359
1881
O34.2
ICD-10 Finland
Maternal care due to uterine scar from previous surgery
2.3
26.4
257
1167
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.9
26.2
166
591
A10AE05
ATC
insulin detemir; parenteral
2.9
24.9
159
571
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.9
24.2
151
535
63710
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Eclampsia
+∞
24.0
23
*
Z34.8
ICD-10 Finland
Supervision of other normal pregnancy
1.7
23.4
554
3507
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.8
23.3
476
2881
Z32.1
ICD-10 Finland
Pregnancy confirmed
1.9
23.2
373
2085
MAA00
NOMESCO Finland
Amniocentesis
3.4
23.1
116
353
63799
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Toxaemia, unspecified
+∞
22.9
22
*
C07AB07
ATC
bisoprolol; oral
1.5
22.0
1132
8639
E66.00
ICD-10 Finland
Metabolic syndrome
2.5
21.4
168
682
N02AX02
ATC
tramadol; systemic, rectal
1.4
20.1
1181
9210
O80.0
ICD-10 Finland
Spontaneous vertex delivery
1.5
20.1
964
7218
O99.2
ICD-10 Finland
Endocrine, nutritional and metabolic diseases complicating pregnancy, childbirth and the puerperium
3.8
19.8
85
229
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.3
19.6
179
788
N02BE01
ATC
paracetamol; systemic, rectal
1.5
18.8
2767
25492
J01DA01
ATC
[U] cefalexin; systemic
1.4
18.5
2000
17320
65700
ICD-8 Finland
Occipital presentation
3.9
18.3
75
194
160
Kela drug reimbursment
exenatide
3.9
18.2
76
200
6424B
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Mild or unspecified pre-eclampsia[PRAE-ECLAMPSIA LEVIS, SYNNYTYKSEN AIKANA]
+∞
17.7
17
*
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.6
17.6
458
2956
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.4
17.4
1400
11470
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.5
17.1
811
6021
B01AB05
ATC
enoxaparin; parenteral
1.4
17.0
863
6492
ZXD05
NOMESCO Finland
Urgent procedure
1.4
17.0
907
6887
A10BJ06
ATC
semaglutide; parenteral
2.9
17.0
104
365
Z39.2
ICD-10 Finland
Routine postpartum follow-up
1.6
16.9
457
2977
MA1AE
NOMESCO Finland
Ultrasound examination of early pregnancy (before 12. postmenstrual week)
1.7
16.9
366
2244
O12
ICD-10 Finland
Gestational [pregnancy-induced] oedema and proteinuria without hypertension
+∞
16.7
16
*
Z35.9
ICD-10 Finland
Supervision of high-risk pregnancy, unspecified
2.5
16.6
129
521
XMA22
NOMESCO Finland
General examination of pregnant woman
2.0
16.4
217
1124
66180
ICD-8 Finland
Occipital presentation
2.7
16.4
111
416
N39.1
ICD-10 Finland
Persistent proteinuria, unspecified
9.0
16.4
34
38
310
Kela drug reimbursment
Orlistat, sibutramine and other major and expensive medicines used to treat obesity
4.4
16.4
59
136
SPAT1357
SPAT
Monitoring of problem during pregnancy
2.6
16.2
119
467
Z30.2
ICD-10 Finland
Sterilization
1.6
15.8
393
2504
T82
ICPC
Obesity
2.3
15.7
145
643
C08CA01
ATC
amlodipine; oral
1.5
15.7
752
5578
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.5
15.6
665
4816
C09CA01
ATC
losartan; oral
1.5
15.6
564
3942
SPAT1379
SPAT
Health check-up of pregnant person
1.7
15.5
372
2347
O99.89
ICD-10 Finland
Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium
3.1
15.4
86
286
E66.9
ICD-10 Finland
Obesity, unspecified
2.5
15.2
121
498
63499
ICD-8 Finland
Other complications of pregnancy, Other
2.8
15.0
96
347
A10BH01
ATC
sitagliptin; oral
2.0
15.0
200
1043
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.7
14.8
359
2268
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.6
14.7
448
3005
SPAT1196
SPAT
Monitoring of normal pregnancy
1.8
14.6
259
1490
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
3.4
14.5
69
204
MAC96
NOMESCO Finland
Other induction or advancement of labour
2.6
14.5
106
416
O16
ICD-10 Finland
Unspecified maternal hypertension
27.3
14.3
19
7
MAC10
NOMESCO Finland
Antepartum dilatation of cervical canal
2.9
14.2
85
296
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
14.2
1131
9157
SPAT1262
SPAT
Handing over of treatment supplies
1.6
14.2
418
2782
P01AB01
ATC
metronidazole; oral, rectal
1.3
14.2
1364
11379
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
13.8
1661
14302
J01DB01
ATC
cefalexin; oral
1.4
13.7
2579
23780
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
13.6
794
6087
O61.0
ICD-10 Finland
Failed medical induction of labour
4.1
13.6
52
128
Z34.9
ICD-10 Finland
Supervision of normal pregnancy, unspecified
1.6
13.5
368
2397
K02.1
ICD-10 Finland
Caries of dentine
1.3
13.5
1767
15386
C09BA02
ATC
enalapril and diuretics; systemic
2.1
13.4
160
797
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.6
13.3
385
2545
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
2.3
13.2
117
510
A10BJ02
ATC
liraglutide; parenteral
2.9
13.2
78
271
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
13.1
1816
15912
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.6
13.0
373
2459
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
13.0
172
890
A10BK03
ATC
empagliflozin; oral
2.0
13.0
164
836
J01AA02
ATC
doxycycline; systemic
1.4
13.0
2474
22716
O36.5
ICD-10 Finland
Maternal care for poor fetal growth
2.6
12.8
95
377
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.6
12.6
364
2407
Z36.0
ICD-10 Finland
Antenatal screening for chromosomal anomalies
1.9
12.6
187
1016
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.3
12.6
1735
15152
R51.80
ICD-10 Finland
Headache
1.5
12.6
480
3385
WX110
NOMESCO Finland
Local anesthesy
1.3
12.5
2166
19533
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
12.3
616
4579
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
12.3
1194
9903
G47.3
ICD-10 Finland
Sleep apnoea
1.5
12.3
456
3194
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
12.3
513
3683
C10AA01
ATC
simvastatin; oral
1.4
12.2
877
6944
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.6
12.2
91
362
M79.6
ICD-10 Finland
Pain in limb
1.3
12.2
1074
8784
H02AB06
ATC
prednisolone; systemic
1.3
12.0
1337
11296
C09CA06
ATC
candesartan; oral
1.4
12.0
581
4288
M54.5
ICD-10 Finland
Low back pain
1.3
12.0
997
8074
MA2XE
NOMESCO Finland
Other obstetric ultrasound examination
1.8
11.9
225
1324
SPAT1263
SPAT
Sampling
1.3
11.9
1260
10575
O30.0
ICD-10 Finland
Twin pregnancy
2.8
11.9
74
266
O82.0
ICD-10 Finland
Delivery by elective caesarean section
1.9
11.8
163
860
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
11.8
860
6818
A10BX07
ATC
[U] liraglutide; parenteral
3.9
11.8
48
126
A12BA01
ATC
potassium chloride; oral
2.6
11.8
83
322
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
2.5
11.8
93
384
O26.88
ICD-10 Finland
Other specified pregnancy-related conditions
3.3
11.7
58
179
W78
ICPC
Pregnancy
1.5
11.7
468
3330
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
11.6
1185
9878
C03AA03
ATC
hydrochlorothiazide; oral
1.7
11.5
223
1323
6425A
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, ENNEN SYNNYTYSTÄ]
+∞
11.5
11
*
6425B
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Severe pre-eclampsia[PRAE-ECLAMPSIA GRAVIS, SYNNYTYKSEN AIKANA]
+∞
11.5
11
*
O11
ICD-10 Finland
Pre-eclampsia superimposed on chronic hypertension
+∞
11.5
11
*
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.4
11.5
766
5988
J01FF01
ATC
clindamycin; systemic
1.4
11.4
752
5861
A08AB01
ATC
orlistat; oral
4.9
11.4
36
74
C10AA05
ATC
atorvastatin; oral
1.4
11.3
787
6186
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.7
11.3
75
279
C07AB02
ATC
metoprolol; systemic
1.5
11.3
436
3078
H04AA01
ATC
glucagon; nasal, parenteral
2.9
11.3
68
241
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
3.0
11.2
62
207
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
2.7
11.2
78
298
SAA01
NOMESCO Finland
Simple examination of mouth
1.3
11.2
2248
20500
SAA02
NOMESCO Finland
Basic examination of mouth
1.3
11.2
2058
18544
QBJ30
NOMESCO Finland
Correction of abdominal apron
3.9
11.1
44
113
SPAT1197
SPAT
Extensive health check-up of expecting family
1.5
11.1
416
2916
ACC51
NOMESCO Finland
Release of median nerve
1.7
11.1
231
1399
N03AX12
ATC
gabapentin; oral
1.5
11.0
432
3057
Z36.4
ICD-10 Finland
Antenatal screening for fetal growth retardation using ultrasound and other physical methods
3.0
11.0
63
214
WX290
NOMESCO Finland
Other blockade of nerve
1.3
10.7
1356
11602
A10BB12
ATC
glimepiride; oral
2.2
10.7
111
523
162
Kela drug reimbursment
liraglutide
3.7
10.7
45
122
8221
FHL
Sterilization of the laparotomy pathway
2.0
10.7
140
726
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.3
10.7
1499
12999
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
5.4
10.7
31
58
O20.0
ICD-10 Finland
Threatened abortion
2.2
10.7
103
470
25000
ICD-8 Finland
Diabetes mellitus, Sine complicatione
2.9
10.7
64
226
MBA03
NOMESCO Finland
Curettage of uterus after delivery or abortion
2.1
10.6
119
579
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.4
10.5
495
3634
C09DA01
ATC
losartan and diuretics; oral
1.7
10.4
233
1438
O20.9
ICD-10 Finland
Haemorrhage in early pregnancy, unspecified
2.2
10.4
101
462
63709
ICD-8 Finland
Pre-eclampsia, eclampsia and toxaemia, unspecified, Prae-eclampsia NUD
+∞
10.4
10
*
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.4
10.3
539
4034
SGA01
NOMESCO Finland
Tooth opening as first aid
1.4
10.2
460
3346
C10AA07
ATC
rosuvastatin; oral
1.4
10.2
564
4263
L03
ICPC
Low back symptom/complaint
1.3
10.1
714
5610
T89
ICPC
Diabetes insulin dependent
2.3
10.1
93
413
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.9
10.1
147
792
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
9.9
489
3615
SGA02
NOMESCO Finland
Opening and dilatation of root canal of tooth
1.5
9.9
341
2343
SPAT1324
SPAT
Screening procedure
1.3
9.8
768
6127
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
9.8
808
6496
R03AC02
ATC
salbutamol; inhalant
1.3
9.8
1645
14528
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
9.8
487
3606
O24.1
ICD-10 Finland
Diabetes mellitus in pregnancy: Pre-existing diabetes mellitus, non-insulin-dependent
5.0
9.7
30
61
S18
ICPC
Laceration/cut
1.3
9.6
1080
9060
C08CA13
ATC
lercanidipine; oral
1.6
9.6
270
1773
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
9.5
1047
8758
Z87.5
ICD-10 Finland
Personal history of complications of pregnancy, childbirth and the puerperium
3.6
9.5
41
115
SPAT1097
SPAT
Recording of ECG
1.5
9.5
351
2451
MAC40
NOMESCO Finland
Pharmacological induction or advancement of labor
2.7
9.4
62
233
65710
ICD-8 Finland
Occipital presentation
2.3
9.4
87
391
A46
ICD-10 Finland
Erysipelas
1.6
9.4
265
1741
O10.9
ICD-10 Finland
Unspecified pre-existing hypertension complicating pregnancy, childbirth and the puerperium
+∞
9.4
9
*
O99.80
ICD-10 Finland
The fear of childbirth
1.8
9.3
165
953
A10BD07
ATC
metformin and sitagliptin; systemic
2.3
9.3
85
378
EBA00
NOMESCO Finland
Extraction of tooth
1.3
9.3
879
7200
WZA90
NOMESCO Finland
Other doctors statement
1.3
9.3
633
4944
63497
ICD-8 Finland
Other complications of pregnancy, Partus prematurus imminens, alibi non classificabilis
2.0
9.3
120
620
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
9.2
284
1906
Z35.2
ICD-10 Finland
Supervision of pregnancy with other poor reproductive or obstetric history
2.5
9.2
71
292
O60
ICD-10 Finland
Preterm labour and delivery
2.2
9.2
95
448
8811
FHL
Cesarean section
1.6
9.1
213
1336
78900
ICD-8 Finland
Abnormal urinary constituents of unspecified cause, Albuminuria
11.5
9.1
16
14
L86
ICPC
Back syndrome with radiating pain
1.8
9.0
159
918
O68.0
ICD-10 Finland
Labour and delivery complicated by fetal heart rate anomaly
1.8
9.0
162
942
O40
ICD-10 Finland
Polyhydramnios
3.0
9.0
48
159
A10BH05
ATC
linagliptin; oral
2.3
8.9
78
342
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
8.9
286
1940
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
1.6
8.9
221
1408
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
8.9
1125
9563
O41.0
ICD-10 Finland
Oligohydramnios
2.4
8.8
71
299
O26.82
ICD-10 Finland
Exhaustion and fatigue pregnancy-related
2.4
8.8
70
290
J01CA04
ATC
amoxicillin; systemic
1.3
8.8
2571
24137
66120
ICD-8 Finland
Occipital presentation
9.5
8.8
17
18
C02AC05
ATC
moxonidine; oral
2.2
8.7
85
393
A10BX04
ATC
[U] exenatide; parenteral
4.0
8.7
33
83
R75
ICPC
Sinusitis acute/chronic
1.7
8.7
163
958
K04.0
ICD-10 Finland
Pulpitis
1.5
8.7
276
1866
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
3.3
8.6
42
130
C08CA05
ATC
nifedipine; systemic
1.9
8.6
131
718
N08.2*D89.80
ICD-10 Finland
Immunoglobulin A (IgA) nephropathy
6.1
8.6
22
36
A10BK01
ATC
dapagliflozin; oral
2.1
8.6
93
449
O28.8
ICD-10 Finland
Other abnormal findings on antenatal screening of mother
3.2
8.5
43
137
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
2.4
8.5
71
304
C07AG02
ATC
carvedilol; oral
2.0
8.5
106
545
R02
ICPC
Shortness of breath/dyspnoea
1.5
8.4
299
2070
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.6
8.4
205
1298
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
8.4
2121
19484
R06.0
ICD-10 Finland
Dyspnoea
1.3
8.4
610
4801
SPAT1301
SPAT
No procedures
1.3
8.3
827
6806
K86
ICPC
Hypertension uncomplicated
1.5
8.3
248
1654
R05
ICPC
Cough
1.3
8.2
669
5353
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.2
8.2
1395
12239
A10AE06
ATC
insulin degludec; parenteral
2.3
8.2
72
316
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
3.5
8.1
36
104
2500B
ICD-9 Finland
Diabetes mellitus without mention of complication[DIABETES MELLITUS SINE COMPLICATIONE ,TYYPPI I]
2.6
8.1
57
224
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
8.1
337
2412
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
8.1
868
7210
A10BJ01
ATC
exenatide; parenteral
4.2
8.1
29
70
R09
ICPC
Sinus symptom/complaint
1.5
8.1
273
1871
O36.3
ICD-10 Finland
Maternal care for signs of fetal hypoxia
4.0
8.0
30
75
L08
ICPC
Shoulder symptom/complaint
1.4
8.0
501
3850
O24.9
ICD-10 Finland
Diabetes mellitus in pregnancy, unspecified
2.4
8.0
62
256
O21.9
ICD-10 Finland
Vomiting of pregnancy, unspecified
2.9
8.0
46
159
25009
ICD-8 Finland
Diabetes mellitus, Unspecified
5.3
8.0
23
44
C10AX09
ATC
ezetimibe; oral
1.6
8.0
210
1360
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.7
7.8
170
1043
Z01.8
ICD-10 Finland
Other specified special examinations
1.3
7.7
581
4592
-1
NOMESCO Finland
NA
1.3
7.7
967
8178
C02EA02
ATC
NA
2.5
7.7
60
247
SPAT1310
SPAT
Counselling related to known health issue
1.3
7.7
893
7484
A10AA02
ATC
NA
2.2
7.5
69
312
N03AX16
ATC
pregabalin; oral
1.3
7.5
640
5149
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.4
7.5
365
2691
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.3
7.5
776
6408
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.5
7.5
227
1518
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
2.7
7.5
49
186
MAC01
NOMESCO Finland
Rupture of aminiotic membrane for induction of labor
2.4
7.4
58
240
H01
ICPC
Ear pain/earache
1.4
7.4
307
2195
C07AB03
ATC
atenolol; systemic
1.9
7.4
109
594
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.4
7.4
397
2977
B01AC04
ATC
clopidogrel; oral
1.5
7.3
215
1429
V230A
ICD-9 Finland
Supervision of high-risk pregnancy, Pregnancy with history of infertility
2.7
7.3
47
176
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.5
7.3
282
1991
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.2
7.3
1108
9570
Z32.0
ICD-10 Finland
Pregnancy, not (yet) confirmed
2.1
7.3
81
398
Z34.0
ICD-10 Finland
Supervision of normal first pregnancy
1.4
7.2
395
2970
SPAT1380
SPAT
Postpartum check-up
1.5
7.2
284
2010
M04AA01
ATC
allopurinol; systemic
1.7
7.2
157
966
KMAK
NOMESCO Finland
NA
1.2
7.2
1631
14683
65300
ICD-8 Finland
Occipital presentation
2.7
7.2
46
170
A03
ICPC
Fever
1.4
7.1
442
3390
66110
ICD-8 Finland
Occipital presentation
3.7
7.1
29
79
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
7.1
223
1505
A10AA01
ATC
NA
2.2
7.0
63
283
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
7.0
302
2176
SGA03
NOMESCO Finland
Demanding opening and dilatation of root canal of tooth
1.5
7.0
259
1810
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.5
7.0
226
1536
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.8
7.0
42
152
O82.11
ICD-10 Finland
Childbirth with an emergency caesarean section in an emergency
2.8
7.0
41
146
J45.1
ICD-10 Finland
Nonallergic asthma
1.6
6.8
179
1158
O21.1
ICD-10 Finland
Hyperemesis gravidarum with metabolic disturbance
4.8
6.8
21
44
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
6.8
276
1965
R07.4
ICD-10 Finland
Chest pain, unspecified
1.3
6.8
623
5059
C07BB07
ATC
bisoprolol and thiazides; systemic
1.9
6.8
96
517
C09DA06
ATC
candesartan and diuretics; oral
1.6
6.8
151
937
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.4
6.7
283
2031
K04.5
ICD-10 Finland
Chronic apical periodontitis
1.3
6.7
641
5234
EBA10
NOMESCO Finland
Surgical removal of tooth
1.4
6.7
308
2248
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.4
6.6
286
2062
O36.8
ICD-10 Finland
Maternal care for other specified fetal problems
2.3
6.6
56
242
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
6.6
1023
8827
O03.4
ICD-10 Finland
Spontaneous abortion, Incomplete, without complication
2.0
6.6
76
379
C01DA14
ATC
isosorbide mononitrate; oral
1.6
6.6
159
1007
L03.0
ICD-10 Finland
Cellulitis of finger and toe
1.6
6.6
167
1075
M17.9
ICD-10 Finland
Gonarthrosis, unspecified
1.4
6.6
281
2023
O02.1
ICD-10 Finland
Missed abortion
1.6
6.6
176
1147
O47.1
ICD-10 Finland
False labour at or after 37 completed weeks of gestation
1.7
6.5
119
699
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.6
6.5
165
1058
WX307
NOMESCO Finland
Obstetric epidural analgesia
1.5
6.5
246
1726
AN1
HP
Coronary angiography
1.6
6.5
152
954
E66
ICD-10 Finland
Obesity
1.7
6.5
122
724
TPH04
NOMESCO Finland
Cathetrisation of vein
1.3
6.5
475
3738
SPAT1283
SPAT
Restricted health certificate
1.3
6.5
552
4433
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
6.4
416
3212
6488A
ICD-9 Finland
Other current conditions in the mother classifiable elsewhere but complicating pregnancy, childbirth and the puerperium, Abnormal glucose tolerance
2.2
6.4
59
269
XF600
NOMESCO Finland
Bloodpressure measurement
1.7
6.4
130
788
D73
ICPC
Gastroenteritis presumed infection
2.0
6.4
77
392
SPAT1260
SPAT
Consultation of another employee
1.3
6.4
455
3566
MAC00
NOMESCO Finland
Rupture of amniotic membrane
4.7
6.4
20
43
27799
ICD-8 Finland
Obesity not specified as of endocrine origin
4.1
6.4
23
57
H3600, E103
ICD-10 Finland
NA
3.2
6.4
30
93
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
1.9
6.4
93
509
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
6.3
298
2184
L17
ICPC
Foot/toe symptom/complaint
1.3
6.3
661
5452
O23.1
ICD-10 Finland
Infections of bladder in pregnancy
4.6
6.3
20
44
6426A
ICD-9 Finland
Hypertension complicating pregnancy, childbirth and the puerperium, Eclampsia[ECLAMPSIA , ENNEN SYNNYTYSTÄ]
+∞
6.2
6
*
A10BD03
ATC
metformin and rosiglitazone; systemic
3.1
6.2
31
100
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.3
6.2
441
3449
M16.1
ICD-10 Finland
Other primary coxarthrosis
1.5
6.2
228
1593
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
6.2
1516
13671
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
1.5
6.2
178
1179
O26.7
ICD-10 Finland
Subluxation of symphysis (pubis) in pregnancy, childbirth and the puerperium
2.8
6.2
36
128
H66.0
ICD-10 Finland
Acute suppurative otitis media
1.6
6.2
167
1091
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
6.1
722
6037
R96
ICPC
Asthma
1.4
6.1
238
1680
O03.9
ICD-10 Finland
Spontaneous abortion, Complete or unspecified, without complication
1.6
6.1
135
836
J01MA02
ATC
ciprofloxacin; systemic
1.2
6.1
952
8208
R06.5
ICD-10 Finland
Mouth breathing
1.5
6.1
177
1173
Z30.1
ICD-10 Finland
Insertion of (intrauterine) contraceptive device
1.3
6.1
384
2954
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
3.2
6.1
29
91
O68.3
ICD-10 Finland
Labour and delivery complicated by biochemical evidence of fetal stress
3.6
6.1
25
70
4019X
ICD-9 Finland
Essential hypertension, Unspecified
3.0
6.1
32
108
N04.9
ICD-10 Finland
Nephrotic syndrome, unspecified
6.7
6.0
14
21
O26.6
ICD-10 Finland
Liver disorders in pregnancy, childbirth and the puerperium
2.2
6.0
56
258
O04.9
ICD-10 Finland
Medical abortion, complete or unspecified, without complication
1.4
6.0
280
2046
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
6.0
253
1817
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3020682) Albumin/Creatinine [Ratio] in Urine
1224
7609
1.92
69.00
5.1
3.8
mg/mmol
21.1
7.0
8.96
847
4334
(3012516) Albumin [Mass/volume] in Urine
1169
7251
1.91
65.67
4.2
3.1
mg/l
453.7
478.4
0.06
808
4035
(3009508) Creatinine [Moles/volume] in Urine
1236
8062
1.81
57.50
4.3
3.1
mmol/l
6.8
6.8
0.09
1105
6753
(3026493) Urate [Moles/volume] in Serum or Plasma
1014
6908
1.65
36.86
2.7
2.2
umol/l
3257.4
3466.0
0.06
887
5966
(3019150) Specific gravity of Urine by Refractometry
933
6510
1.58
29.60
5.0
4.0
kg/l
1.0
1.0
1.19
173
1002
(3035350) Ketones [Presence] in Urine by Test strip
1892
15372
1.49
29.09
4.4
3.6
estimate
0.0
0.0
0.13
369
2855
(3013826) Glucose [Moles/volume] in Serum or Plasma
2007
16631
1.47
27.03
4.7
3.9
mmol/l
6.7
6.4
7.42
1855
15283
(3021601) Nitrite [Presence] in Urine by Test strip
1894
15530
1.46
26.88
5.7
4.8
estimate
0.0
0.0
0.80
377
2893
(3029937) Albumin [Presence] in Urine by Test strip
1105
8148
1.51
26.81
4.9
3.9
estimate
0.0
0.0
0.81
362
2892
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1505
11817
1.47
26.69
4.6
3.7
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
1897
15666
1.44
25.25
4.5
3.6
estimate
0.0
0.0
0.23
359
2896
(3037467) Urinalysis macro (dipstick) panel - Urine
2456
21723
1.41
19.49
5.2
4.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
3346
31575
1.82
19.32
15.1
12.6
mmol/l
139.7
139.7
0.22
3302
30733
(3023103) Potassium [Moles/volume] in Serum or Plasma
3351
31672
1.81
18.73
15.3
12.7
mmol/l
3.9
3.9
7.22
3304
30745
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
116
473
2.50
18.44
2.6
2.4
ug/min
206.5
48.8
1.20
70
281
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
928
7050
1.43
17.90
1.9
1.7
mg/l
1.0
0.9
0.17
743
5286
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1180
9362
1.39
17.64
2.5
2.4
u/l
52.7
57.5
2.51
1121
8574
(3031040) Bacteria [#/volume] in Urine by Automated count
2364
21035
1.36
16.30
5.1
4.3
e6/l
595.3
1710.1
1.65
34
243
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
847
6438
1.41
16.02
2.6
2.6
ng/l
948.5
798.1
0.42
713
5393
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2998
27824
1.46
15.59
6.6
5.0
mmol/mol
40.3
38.4
22.82
2855
25822
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1216
9886
1.35
14.98
3.2
3.0
ng/l
32.0
94.4
0.56
689
5589
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2594
23538
1.36
14.97
7.1
7.2
u/l
76.4
75.6
0.35
2472
22122
(3011397) Hemoglobin [Presence] in Urine by Test strip
925
7233
1.37
14.56
4.5
3.6
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3304
31381
1.63
14.55
13.7
11.9
mg/l
19.8
19.8
0.00
2705
24232
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
388
2585
1.56
14.12
3.2
4.3
u/l
235.3
237.6
0.10
365
2448
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1785
15449
1.31
13.77
5.0
5.8
umol/l
9.6
9.8
0.41
1699
14578
(3024561) Albumin [Mass/volume] in Serum or Plasma
1458
12285
1.31
13.66
5.1
4.3
g/l
35.5
36.2
5.08
1384
11376
(40768446) Kidney Pathology biopsy report
35
83
4.25
13.61
1.5
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
756
5807
1.38
13.08
3.1
2.4
e6/l
6.8
8.1
2.03
666
5043
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
173
956
1.85
12.66
1.9
1.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1187
9799
1.31
12.63
3.3
2.8
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
1228
10188
1.31
12.59
6.8
6.3
inr
1.1
1.1
0.17
378
3117
(3044889) 12 lead EKG panel
2302
20762
1.30
12.37
3.7
3.3
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
54
183
2.98
12.35
3.2
1.6
g/24h
0.9
1.2
—
6
11
(3018095) Leukocytes [#/volume] in Urine
1234
10284
1.30
12.13
4.1
3.4
e6/l
90.5
86.8
0.06
879
6782
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
273
1738
1.62
12.03
2.3
2.1
ug/l
5.1
5.9
0.39
247
1498
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
288
1868
1.59
11.74
2.1
2.1
u/l
8834.8
4826.1
0.77
114
759
(3041096) Erythrocytes [Presence] in Urine by Automated
1037
8475
1.31
11.67
3.8
3.2
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
293
1913
1.58
11.62
4.9
3.4
kpa
5.8
5.8
0.02
285
1859
(3002582) Erythrocytes [#/volume] in Urine
1012
8248
1.32
11.61
3.7
2.9
e6/l
28.8
78.5
1.96
786
6146
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
160
897
1.82
11.21
2.3
1.8
g/l
1.4
1.6
2.37
142
769
(3013707) Erythrocyte sedimentation rate by Westergren method
2572
23679
1.30
11.06
4.3
4.1
mm/h
12.7
11.5
4.98
2444
22013
(3018418) pH of Serum or Plasma
1068
8822
1.30
10.97
4.6
3.6
ph
7.4
7.4
0.80
185
1693
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
68
282
2.44
10.57
1.6
1.4
mmol/l
13.0
11.8
—
8
43
(3002032) Base excess in Venous blood by calculation
286
1901
1.55
10.48
5.7
3.4
mmol/l
1.6
2.0
1.07
244
1571
(3023368) Bacteria identified in Blood by Culture
791
6304
1.33
10.47
3.9
3.9
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1661
14561
1.26
10.38
7.3
5.7
mmol/l
1.2
1.2
0.04
1429
12201
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
78
348
2.27
10.30
1.8
1.6
mmol/l
7.4
7.5
0.13
45
219
(3030467) Casts [#/volume] in Urine by Automated count
935
7649
1.30
10.20
3.4
2.8
e6/l
0.3
0.3
0.11
717
5607
(3043409) Potassium [Moles/volume] in Arterial blood
118
621
1.93
10.09
4.2
4.0
mmol/l
3.8
3.8
1.22
109
587
(3034274) Bile acid [Moles/volume] in Serum --fasting
110
566
1.97
10.05
2.3
2.1
umol/l
4.7
5.4
0.58
76
415
(36304419) Bacteria [Presence] in Urine
923
7556
1.30
9.98
3.3
2.7
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
153
888
1.75
9.59
3.3
2.8
g/l
0.5
0.3
1.49
77
303
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
140
796
1.79
9.42
2.4
2.4
g/l
3.8
3.5
1.45
128
753
(3014576) Chloride [Moles/volume] in Serum or Plasma
389
2814
1.43
9.35
7.2
6.2
mmol/l
104.2
104.6
0.93
375
2761
(3022217) INR in Platelet poor plasma by Coagulation assay
396
2881
1.42
9.22
20.0
17.2
inr
1.2
1.2
0.21
69
456
(3030981) Hyaline casts [#/volume] in Urine by Automated count
198
1250
1.62
9.07
3.5
2.4
e6/l
0.3
0.3
0.03
191
1203
(3007853) Bacteria identified in Skin by Aerobe culture
444
3306
1.39
9.04
1.8
1.6
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
771
6245
1.30
8.90
1.3
1.3
u/ml
10.3
11.9
0.31
304
2526
(3008152) Bicarbonate [Moles/volume] in Arterial blood
208
1335
1.59
8.90
6.5
7.0
mmol/l
24.5
24.6
0.18
196
1232
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2849
26838
1.29
8.75
5.0
4.5
pmol/l
14.7
14.6
0.91
2704
24748
(3020779) Urea [Moles/volume] in Serum or Plasma
273
1872
1.50
8.66
10.3
6.7
mmol/l
9.4
8.1
2.66
268
1798
(40761535) Cells panel - Urine sediment
316
2231
1.46
8.66
3.9
3.4
—
—
—
0
0
(3026250) Tacrolimus [Mass/volume] in Blood
29
84
3.47
8.63
36.2
31.4
ug/l
7.0
7.5
0.53
29
77
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
179
1119
1.63
8.54
1.7
1.5
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
431
3223
1.38
8.54
7.8
4.6
mmol/l
1.1
1.0
2.22
412
2980
(3027273) Bicarbonate [Moles/volume] in Venous blood
161
981
1.67
8.49
4.0
2.9
mmol/l
25.3
25.4
0.13
155
952
(3016502) Oxygen saturation in Arterial blood
309
2183
1.45
8.44
6.8
7.2
%
96.6
96.2
1.33
299
2101
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
622
4926
1.32
8.43
3.1
3.2
ng/l
166.2
276.2
0.85
411
3235
(3024354) Oxygen [Partial pressure] in Venous blood
232
1549
1.53
8.36
3.9
2.8
kpa
4.8
4.7
0.30
225
1498
(3002173) Hemoglobin [Mass/volume] in Arterial blood
292
2060
1.45
8.04
7.1
7.5
g/l
119.1
119.9
0.31
281
1983
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
794
6534
1.28
8.00
1.3
1.3
iu/ml
22.7
29.2
1.34
271
2096
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1671
14931
1.22
7.94
4.1
3.8
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
153
938
1.66
7.91
4.2
2.5
%
0.7
0.7
0.14
148
897
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
578
4573
1.31
7.86
2.7
2.4
e6/l
1.2
1.3
0.14
342
2461
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
515
4014
1.33
7.78
1.7
1.8
—
—
—
0
0
(3003396) Base excess in Arterial blood by calculation
347
2542
1.40
7.76
6.5
6.7
mmol/l
1.0
1.1
0.05
270
1981
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
365
2699
1.39
7.73
1.5
1.7
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1184
10257
1.23
7.49
3.2
3.1
u/l
29.6
30.7
0.40
1119
9734
(3000034) Microalbumin [Mass/volume] in Urine
55
244
2.27
7.46
3.7
2.9
mg/l
182.0
22.7
1.84
41
164
(3026782) Osmolality of Urine
649
5249
1.29
7.45
3.1
2.6
mosm/kgh2o
522.0
508.9
0.82
558
4447
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
346
2551
1.39
7.45
6.6
6.6
kpa
5.0
5.1
0.49
329
2433
(3027801) Oxygen [Partial pressure] in Arterial blood
345
2549
1.39
7.34
6.6
6.6
kpa
12.6
13.2
1.22
326
2429
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
522
4110
1.32
7.32
1.8
1.9
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
111
637
1.77
7.32
3.6
2.9
mg/l
1.5
1.4
0.84
103
596
(3019060) Gas panel - Arterial blood
207
1393
1.52
7.22
3.9
5.1
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
360
2694
1.37
7.09
1.5
1.7
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
13
23
5.67
7.06
14.0
13.6
mmol/l
4.8
5.4
0.29
13
23
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
45
190
2.39
6.85
1.6
1.4
nmol/l
1.6
1.4
0.50
40
172
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
151
959
1.60
6.82
4.3
2.6
%
1.4
1.2
0.60
151
947
(3014007) Fractional oxyhemoglobin in Arterial blood
200
1360
1.50
6.66
8.3
7.9
%
94.5
94.4
0.26
200
1354
(3022948) Iron [Moles/volume] in Serum or Plasma
529
4231
1.29
6.58
3.2
2.2
umol/l
12.8
13.6
1.78
500
3910
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
3150
30317
1.31
6.55
5.8
5.3
mu/l
1.8
2.0
1.82
2999
28178
(3018677) aPTT in Platelet poor plasma by Coagulation assay
477
3775
1.30
6.42
2.1
2.0
s
29.1
29.2
0.31
462
3657
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
253
1815
1.42
6.39
2.1
2.7
ng/l
158.2
135.0
0.33
223
1641
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
737
6156
1.25
6.39
1.7
1.6
pmol/l
432.2
39098628.7
5.53
652
5123
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
45
197
2.30
6.35
1.8
2.0
u/field
2.2
2.4
0.04
24
84
(3003338) MCHC [Mass/volume]
2834
26964
1.24
6.30
18.4
15.2
g/l
331.1
331.1
0.03
2812
26797
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1469
13159
1.20
6.28
6.3
5.0
mmol/l
1.2
1.2
0.30
1364
11877
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3409
33248
1.46
6.22
11.0
9.9
u/l
25.1
23.8
2.59
3346
32086
(3013650) Neutrophils [#/volume] in Blood by Automated count
1965
18084
1.19
6.14
7.9
9.1
e9/l
4.1
3.9
3.72
1743
15874
(3000991) Gas panel - Venous blood
249
1795
1.42
6.13
9.5
7.3
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
88
502
1.77
5.99
2.8
2.1
nmol/l
0.9
0.8
0.91
76
425
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1327
11833
1.19
5.86
1.9
1.9
pmol/l
95.2
100.2
3.42
682
5705
(3022621) pH of Urine by Test strip
280
2080
1.38
5.79
3.3
2.9
—
—
—
0
0
(3020891) Body temperature
131
842
1.58
5.69
5.9
4.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
128
820
1.58
5.64
1.4
1.4
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
96
572
1.70
5.63
1.6
1.3
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
1751
16026
1.18
5.63
5.5
5.8
e9/l
2.0
2.0
0.53
1572
14236
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
89
520
1.73
5.60
1.5
1.3
u/ml
105.3
112.2
0.29
23
121
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
303
2293
1.35
5.58
3.8
2.4
ml/min/173m2
65.4
70.5
1.38
132
865
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
441
3520
1.29
5.55
3.5
2.3
%
21.3
22.6
1.39
391
3008
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
966
8405
1.20
5.52
2.1
2.0
u/l
155.6
149.2
0.11
921
7876
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
513
4186
1.26
5.40
3.0
2.6
e6/l
5.3
4.6
0.48
283
2093
(3004789) Transferrin [Mass/volume] in Serum or Plasma
474
3842
1.27
5.27
3.4
2.2
g/l
2.4
2.4
0.05
443
3540
(3014111) Lactate [Moles/volume] in Serum or Plasma
262
1956
1.37
5.27
7.6
5.9
mmol/l
1.2
1.2
0.25
257
1890
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
92
555
1.67
5.18
1.3
1.2
u/ml
249.6
267.5
0.27
58
356
(3006315) Basophils [#/volume] in Blood
1701
15615
1.17
5.06
5.4
5.9
e9/l
0.0
0.0
0.41
1499
13560
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
33
141
2.35
4.98
1.6
1.8
u/field
3.8
2.6
0.42
25
94
(3037522) Nuclear Ab [Titer] in Serum
592
4956
1.23
4.94
1.4
1.4
titre
602.5
582.5
0.07
110
1092
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
100
627
1.61
4.87
4.3
2.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
469
3833
1.26
4.86
2.0
1.8
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
3116
30148
1.25
4.84
4.9
4.2
mmol/l
6.0
5.7
23.17
2940
27743
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
258
1949
1.35
4.83
1.4
1.7
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
95
590
1.63
4.81
1.2
1.2
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
153
1057
1.47
4.80
1.7
1.9
g/l
0.2
0.2
0.52
147
994
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
497
4096
1.25
4.79
2.0
1.9
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
11
24
4.59
4.78
3.7
5.5
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
831
7227
1.19
4.67
2.5
2.2
mg/l
3.0
2.8
0.91
755
6153
(40761511) CBC panel - Blood by Automated count
3369
32938
1.34
4.65
13.5
11.1
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
1688
15552
1.16
4.64
5.5
5.8
e9/l
0.5
0.5
0.25
1490
13530
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
126
843
1.51
4.64
2.4
2.2
%
186.7
180.3
0.34
116
803
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
75
443
1.71
4.61
1.1
1.3
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
193
1407
1.39
4.53
3.2
3.2
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
1749
16180
1.16
4.50
5.5
6.0
e9/l
0.2
0.2
1.64
1577
14302
(3024471) HLA-A [Type]
19
66
2.89
4.33
1.1
1.0
—
—
—
0
0
(3024932) HLA-DR beta [Type]
19
66
2.89
4.33
1.2
1.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
70
415
1.70
4.27
1.4
1.5
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1507
13827
1.15
4.26
8.9
8.7
e9/l
0.0
0.0
3.20
1260
11297
(3009445) Proteinase 3 Ab [Units/volume] in Serum
158
1126
1.42
4.24
1.9
1.6
u/ml
16.2
8.1
—
5
27
(3045716) Anion gap in Serum or Plasma
25
102
2.46
4.21
3.9
1.9
mmol/l
8.7
9.5
0.68
20
77
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
34
159
2.15
4.21
1.1
1.1
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
42
214
1.97
4.15
1.2
1.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
17
57
2.99
4.12
4.8
4.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
92
596
1.56
3.97
3.3
4.0
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
34
163
2.10
3.97
1.7
2.1
%
103.0
101.7
0.05
29
148
(3016750) Collection duration of Urine
28
124
2.27
3.96
2.3
2.1
min
529.7
499.5
1.06
19
96
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
141
998
1.43
3.95
8.0
3.8
mmol/l
24.2
24.4
0.32
122
911
(3012095) Magnesium [Moles/volume] in Serum or Plasma
514
4352
1.21
3.82
3.0
3.2
mmol/l
0.8
0.8
0.11
486
4042
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
24
101
2.39
3.81
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
135
957
1.43
3.77
1.2
1.2
—
—
—
0
0
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
183
1367
1.36
3.75
3.5
3.1
kpa
5.2
5.2
0.12
168
1280
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
675
5870
1.18
3.74
1.9
1.6
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
209
1596
1.33
3.70
1.5
1.4
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
130
919
1.43
3.69
1.7
1.7
titre
268.6
313.3
—
7
42
(3036481) Cortisol [Moles/volume] in Serum or Plasma
373
3069
1.24
3.66
1.9
2.2
nmol/l
356.1
374.8
1.31
353
2823
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
150
1090
1.39
3.65
1.7
1.9
g/l
1.2
1.2
0.33
144
1026
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
23
97
2.38
3.64
1.0
1.1
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
147
1065
1.40
3.64
2.4
2.0
—
—
—
0
0
(3009343) pH of Capillary blood
180
1350
1.35
3.61
3.5
3.1
ph
7.4
7.4
1.27
22
178
(3002385) Erythrocyte distribution width [Ratio]
2765
26659
1.16
3.45
16.6
14.6
%
13.7
13.6
2.06
2717
26123
(3004775) Volume in Urine collected for unspecified duration
33
166
2.00
3.43
2.5
2.2
ml
642.9
610.9
0.20
24
119
(3015235) Bicarbonate [Moles/volume] in Capillary blood
78
505
1.56
3.42
4.0
2.8
mmol/l
23.7
25.0
1.90
67
445
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
68
428
1.60
3.37
1.1
1.1
iu/ml
80.0
22766.3
0.55
21
106
(3036603) Volume of Urine
37
196
1.90
3.33
1.8
1.4
ml
1879.5
2020.5
0.23
11
35
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3036
29507
1.18
3.33
12.3
10.8
ml/min/173m2
84.5
84.8
0.27
2558
24116
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
94
639
1.48
3.31
3.1
3.3
u/ml
0.4
0.4
0.05
49
359
(3002619) Bacteria identified in Specimen by Culture
16
60
2.67
3.22
1.1
1.2
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
39
214
1.83
3.17
2.0
1.5
mmol/l
6.8
6.2
0.51
29
145
(3036489) Thrombin time
147
1093
1.36
3.15
2.0
1.9
s
21.6
20.9
0.40
130
916
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
78
516
1.52
3.14
5.0
4.7
iu/ml
1693.7
317.4
1.20
16
60
(3022096) Basophils/100 leukocytes in Blood
1518
14134
1.13
3.14
5.6
6.0
%
0.7
0.7
0.87
1426
13143
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
58
358
1.63
3.13
2.2
2.6
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
171
1304
1.33
3.11
3.5
3.1
mmol/l
1.7
1.8
0.13
120
996
(3019832) Treponema pallidum Ab [Presence] in Serum
473
4055
1.19
3.08
1.7
1.6
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
82
551
1.50
3.07
1.7
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3162
30880
1.19
3.07
4.8
4.1
mmol/l
4.8
4.9
11.61
3029
28795
(40768793) Breast Pathology biopsy report
84
1218
0.68
3.04
1.3
1.3
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
106
751
1.42
3.04
1.2
1.4
u/l
22.2
28.8
1.41
92
622
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
7
12
5.84
3.02
1.3
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
64
409
1.57
3.01
1.3
1.6
mu/l
48.7
56.5
0.25
57
367
(3024928) Oxygen saturation in Venous blood
69
449
1.55
3.00
4.7
2.8
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
157
1190
1.33
2.99
8.8
9.0
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
125
916
1.38
2.96
3.8
5.4
%
0.9
0.9
0.46
116
856
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
54
333
1.63
2.95
1.1
1.3
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
24
114
2.11
2.94
1.1
1.1
%
107.7
120.8
0.78
19
101
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1621
15193
1.12
2.94
3.4
2.8
ug/l
86.1
86.0
0.01
1531
14186
(3019069) Monocytes/100 leukocytes in Blood
1570
14691
1.12
2.92
5.8
6.2
%
7.9
8.2
2.79
1484
13760
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
23
109
2.12
2.84
2.1
2.7
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
71
472
1.51
2.83
1.3
1.6
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
82
563
1.47
2.80
1.3
1.3
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
291
2408
1.23
2.76
1.5
1.5
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
6
8.34
2.75
5.4
2.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
3140
30702
1.17
2.71
4.6
4.1
mmol/l
1.5
1.6
34.35
2981
28511
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
124
922
1.36
2.71
3.8
5.3
%
1.6
1.6
0.26
113
857
(3002030) Lymphocytes/100 leukocytes in Blood
1611
15142
1.12
2.70
5.6
6.0
%
29.5
29.4
0.23
1515
14110
(3047181) Lactate [Moles/volume] in Blood
102
735
1.40
2.70
3.7
6.6
mmol/l
1.4
1.2
0.62
85
651
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
23
112
2.06
2.67
1.1
1.1
%
101.3
97.0
—
7
47
(3018010) Neutrophils/100 leukocytes in Blood
1592
14963
1.11
2.66
5.5
5.8
%
56.8
56.4
0.79
1505
13983
(3006504) Eosinophils/100 leukocytes in Blood
1556
14613
1.11
2.63
5.6
6.0
%
2.8
2.8
0.02
1461
13580
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
98
705
1.40
2.62
1.2
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
25
127
1.98
2.60
1.2
2.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
188
1495
1.27
2.55
2.1
1.9
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
39
230
1.70
2.55
2.1
2.0
—
—
—
0
0
(3028717) Thiamine [Mass/volume] in Blood
10
33
3.04
2.52
1.5
1.2
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
802
7264
1.13
2.51
4.1
4.3
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
175
1383
1.28
2.50
1.7
1.5
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
799
7237
1.13
2.50
1.7
1.6
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
3025
29536
1.15
2.47
4.2
3.7
mmol/l
1.3
1.2
17.04
2864
27223
(3043238) Trisomy 21 risk [Likelihood] in Fetus
84
1167
0.71
2.46
1.5
1.5
—
—
—
0
0
(3022313) Gas panel - Capillary blood
128
974
1.33
2.43
3.0
3.2
—
—
—
0
0
(1616796) Gas panel - Central venous blood
74
514
1.45
2.42
3.9
2.9
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
23
117
1.97
2.40
1.1
1.1
%
97.3
91.7
—
7
50
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
15
64
2.35
2.38
1.4
1.2
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
536
4744
1.15
2.36
1.8
1.7
nmol/l
1212.9
1182.7
0.30
461
3550
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
260
3106
0.82
2.36
1.7
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1065
9845
1.12
2.35
2.2
2.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
54
354
1.53
2.35
3.4
2.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2311
22236
1.11
2.34
3.4
3.3
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3193
31325
1.17
2.32
5.3
4.5
mmol/l
2.8
2.9
4.25
3028
29029
(3047352) Trisomy 18 risk [Likelihood] in Fetus
82
1131
0.72
2.31
1.4
1.4
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
15
65
2.31
2.31
4.7
4.2
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
15
65
2.31
2.31
4.7
4.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
41
254
1.62
2.27
1.4
1.6
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1511
14254
1.10
2.24
2.5
2.3
nmol/l
76.0
78.3
2.66
1415
12978
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
74
523
1.42
2.24
1.7
1.4
mmol/l
7.7
7.3
0.41
55
395
(3023511) Choriogonadotropin [Units/volume] in Urine
130
1005
1.30
2.23
1.3
1.3
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
3527
34967
1.38
2.23
21.2
18.0
e9/l
263.7
266.7
2.15
3479
34169
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
10
36
2.78
2.20
1.6
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
120
920
1.31
2.20
2.1
2.0
%
97.1
95.3
0.35
112
840
(3024731) MCV [Entitic volume]
3528
34982
1.38
2.19
21.1
17.9
fl
90.5
90.8
4.34
3508
34555
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
17
80
2.13
2.18
1.1
1.1
—
—
—
0
0
(3035941) MCH [Entitic mass]
3528
34983
1.38
2.18
21.1
17.9
pg
30.0
30.1
3.38
3508
34554
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
327
2806
1.18
2.16
3.2
2.9
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
147
1161
1.28
2.16
1.7
2.0
—
—
—
0
0
(3004446) Plasmodium sp identified in Blood by Light microscopy
9
30
3.00
2.14
1.9
2.7
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
83
1126
0.73
2.14
1.4
1.4
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
522
4647
1.14
2.13
2.1
2.0
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
3528
34988
1.37
2.13
21.2
17.9
e12/l
4.5
4.4
3.31
3469
34106
(3010813) Leukocytes [#/volume] in Blood
3528
34989
1.37
2.11
21.3
18.0
e9/l
6.8
6.6
8.37
3469
34100
(3017143) Hepatitis C virus Ab [Presence] in Serum
439
3864
1.15
2.10
1.7
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
173
2120
0.81
2.05
1.5
1.4
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
15
4.00
2.04
1.2
1.3
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
49
326
1.51
2.03
2.8
3.2
nmol/l
0.8
0.8
0.04
40
256
(3000963) Hemoglobin [Mass/volume] in Blood
3528
34998
1.36
2.02
21.3
18.0
g/l
132.9
132.6
0.68
3508
34566
(3020630) Protein [Mass/volume] in Serum or Plasma
242
2036
1.20
2.01
2.0
2.5
g/l
66.2
67.0
0.79
225
1864
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
14
63
2.23
2.00
1.1
1.2
mg/l
0.8
80.3
—
8
44
(40758558) Short blood count panel - Blood
868
7999
1.11
2.00
6.3
6.8
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
36
224
1.61
1.99
2.8
2.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
44
288
1.53
1.97
1.1
1.1
—
—
—
0
0
(4010399)
267
2272
1.19
1.96
1.4
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
75
546
1.38
1.95
2.4
2.1
g/l
126.3
128.4
0.34
55
386
(3004451) EKG impression Narrative
18
91
1.98
1.95
1.7
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
56
387
1.45
1.94
1.1
1.1
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
62
437
1.43
1.94
3.4
2.5
kpa
8.6
8.3
0.73
56
404
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
11
45
2.45
1.93
1.0
1.2
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
901
8335
1.11
1.92
1.7
1.6
mmol/l
1.4
1.3
2.73
763
7025
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
69
499
1.39
1.88
1.2
1.5
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
61
432
1.42
1.87
1.3
1.5
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
22
122
1.81
1.84
1.8
2.8
—
18.6
—
0
9
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
147
1188
1.25
1.83
8.7
7.8
mmol/l
24.2
24.3
0.24
135
1121
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
51
728
0.70
1.82
1.1
1.5
nmol/l
0.3
0.5
3.13
40
569
(3011648) Oxygen content in Venous blood
29
175
1.66
1.82
3.1
2.1
%
12.4
10.9
1.28
29
175
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
5
12
4.17
1.82
1.0
1.0
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
980
9130
1.10
1.81
1.4
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
67
486
1.39
1.81
1.1
1.1
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
198
2354
0.83
1.77
1.6
1.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
304
2642
1.16
1.76
3.2
3.2
pmol/l
4.5
4.5
0.30
283
2366
(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method
10
41
2.44
1.75
1.0
1.1
nmol/l
0.4
0.4
—
5
23
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
878
8149
1.10
1.75
1.3
1.3
u/ml
1.3
1.6
0.49
260
2232
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
339
2973
1.15
1.74
1.2
1.2
iu/ml
132.6
152.8
0.48
139
1142
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
10
216
0.46
1.70
1.8
1.8
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
500
4508
1.13
1.70
2.1
2.2
ug/g
123.4
105.0
0.66
391
3486
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
8
177
0.45
1.69
11.0
11.3
nmol/l
947.0
907.8
—
8
169
(3000475) Leukocytes [#/volume] in Synovial fluid
86
658
1.31
1.67
1.4
1.7
e6/l
9539.9
9418.7
0.01
68
475
(3000570) Elastase.pancreatic [Mass/mass] in Stool
116
924
1.26
1.66
1.2
1.4
ug/g
318.0
291.2
0.79
70
497
(40761536) Microorganisms panel - Urine sediment
314
2750
1.16
1.65
4.4
3.7
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
73
547
1.34
1.64
1.7
1.6
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
5
131
0.38
1.62
1.6
1.5
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
5
14
3.57
1.61
1.0
1.0
%
7.7
8.3
—
5
14
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
5
14
3.57
1.61
1.0
1.0
%
36.7
36.9
—
5
14
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
5
14
3.57
1.61
1.0
1.0
%
21.9
20.5
—
5
14
(3010421) pH of Blood
85
655
1.30
1.58
3.7
3.0
ph
7.4
7.4
0.30
65
544
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
104
823
1.27
1.58
1.3
1.3
u/ml
2.5
2.9
0.10
12
62
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
7
26
2.70
1.58
2.3
2.6
u/field
0.6
0.7
—
7
26
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
54
388
1.40
1.57
1.3
1.4
pmol/l
258.0
374.3
0.85
46
303
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
207
1764
1.18
1.55
1.5
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
125
1015
1.24
1.53
1.3
1.3
u/ml
10.9
5.5
0.29
18
110
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
14
71
1.98
1.53
1.4
1.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
263
2289
1.16
1.52
5.6
3.0
ng/l
102.6
74.5
4.50
241
1959
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
50
690
0.72
1.52
1.2
1.4
ug/l
12.6
3.7
0.50
41
619
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
94
739
1.28
1.52
1.7
1.6
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
126
1030
1.23
1.47
1.3
1.3
u/ml
6.3
9.4
0.35
22
179
(3012898) Urea [Moles/volume] in Urine
6
22
2.73
1.43
1.0
1.4
mmol/l
115.6
162.2
—
6
22
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
380
3409
1.13
1.43
2.2
2.5
umol/l
5.6
6.2
0.44
323
2883
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
387
3478
1.13
1.41
7.9
5.4
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
797
7437
1.09
1.41
3.6
3.4
%
98.2
97.0
0.74
770
7208
(3008116) Ketones [Moles/volume] in Urine by Test strip
9
40
2.25
1.40
1.3
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
226
1960
1.16
1.39
1.3
1.2
—
—
—
0
0
(4146454)
39
271
1.44
1.39
2.3
2.7
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
33
222
1.49
1.38
1.1
1.2
titre
406.7
151.0
—
9
49
(3025159) Blasts/100 leukocytes in Blood
264
2320
1.15
1.37
3.9
4.1
%
0.0
0.4
0.96
63
501
(3016273) Islet cell 512 Ab [Units/volume] in Serum
5
17
2.94
1.36
1.0
1.1
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
37
0.00
1.34
0.0
1.1
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
342
3807
0.89
1.32
4.3
4.2
%
31.5
33.3
3.12
282
2576
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
25
160
1.57
1.31
1.4
1.2
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
126
1045
1.21
1.31
1.5
1.4
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
9
43
2.10
1.30
3.8
1.8
mmol/l
1.2
1.2
—
9
43
(4024509)
45
326
1.39
1.30
1.5
1.5
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
204
1767
1.16
1.30
1.5
1.8
g/l
1.3
1.4
0.05
189
1616
(3020650) Glucose [Presence] in Urine
14
76
1.85
1.29
1.1
1.6
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
8
34
2.36
1.29
45.1
7.1
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
1088
10320
1.08
1.29
5.4
5.9
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
54
404
1.34
1.28
2.5
2.3
—
588.1
—
0
18
(4062490)
47
345
1.37
1.26
1.1
1.4
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
131
1096
1.20
1.25
1.9
1.9
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
17
100
1.70
1.23
2.1
1.9
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
95
771
1.24
1.23
2.4
2.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
63
487
1.30
1.21
1.0
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
32
221
1.45
1.21
1.5
1.9
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
97
791
1.23
1.20
1.9
2.0
ug/l
2.6
2.1
0.20
86
709
(3017446) Testosterone [Moles/volume] in Serum or Plasma
45
331
1.36
1.20
1.4
1.3
nmol/l
1.1
1.4
0.84
38
262
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
8
38
2.11
1.18
45.1
6.9
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
27
181
1.50
1.18
1.4
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
78
623
1.26
1.17
1.9
2.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
262
2331
1.13
1.16
2.2
2.6
e9/l
4.1
4.1
0.20
219
1895
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
15
248
0.60
1.15
1.3
1.1
—
—
—
0
0
(3035611) Eosinophils/100 leukocytes in Synovial fluid
5
20
2.50
1.15
1.0
2.1
%
0.3
0.1
—
5
13
(3051611) Lipemic interference index of Serum or Plasma
40
292
1.37
1.13
2.7
3.1
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
88
716
1.23
1.13
1.6
1.6
iu/ml
29.3
22.9
—
5
20
(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay
12
65
1.85
1.13
1.0
1.1
—
74.5
—
0
11
(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma
12
65
1.85
1.13
1.0
1.0
ug/l
79.0
75.4
0.11
12
56
(3017181) Myelocytes/100 leukocytes in Blood
285
2555
1.13
1.13
3.7
4.1
%
0.9
0.9
0.12
75
634
(3015171) Extractable nuclear Ab [Units/volume] in Serum
176
1528
1.16
1.12
1.2
1.3
u/ml
0.5
1.5
1.44
19
127
(3024139) IgG subclass 3 [Mass/volume] in Serum
46
345
1.34
1.11
1.1
1.4
g/l
0.4
0.4
0.27
37
235
(3028192) IgG subclass 2 [Mass/volume] in Serum
46
345
1.34
1.11
1.1
1.4
g/l
3.6
2.8
1.39
37
234
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
20
305
0.65
1.10
1.0
1.1
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
46
346
1.33
1.09
1.1
1.4
g/l
6.9
6.8
0.08
37
234
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
81
1.73
1.08
1.3
1.2
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
674
6319
1.08
1.08
1.5
1.5
nmol/l
21.4
21.6
0.16
608
5382
(3037756) Immunofixation for Serum or Plasma
58
453
1.28
1.06
1.2
1.7
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
290
2615
1.12
1.05
2.1
2.2
g/l
0.2
0.2
0.41
276
2464
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
51
392
1.31
1.05
1.3
1.4
—
—
—
0
0
(4035726)
261
2904
0.89
1.04
1.3
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
155
1342
1.16
1.04
2.1
2.0
u/l
37.7
40.0
0.88
142
1221
(3008898) HLA-B27 [Presence]
160
1390
1.16
1.03
1.1
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
45
341
1.32
1.03
1.1
1.1
—
—
—
0
0
(4268621)
47
359
1.31
1.02
2.4
2.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
278
2508
1.12
1.01
2.9
2.5
%
1.9
1.8
1.03
254
2223
(3040370) OLANZapine [Moles/volume] in Serum or Plasma
5
108
0.46
1.00
2.0
2.3
nmol/l
199.8
161.1
—
5
92
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
131
1123
1.17
1.00
1.3
1.3
u/ml
11.6
36.3
—
9
80
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
12
68
1.77
1.00
1.0
1.1
—
71.1
—
0
12
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
22
147
1.50
1.00
1.1
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
19
286
0.66
1.00
1.1
1.2
—
—
—
0
0
(3019225) pH of Specimen
270
2990
0.90
1.00
3.8
3.7
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
7
35
2.00
1.00
1.3
1.0
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
7
35
2.00
1.00
1.0
1.1
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
66
529
1.25
1.00
1.3
1.2
u/ml
2.8
4.3
0.87
28
206
(40767503) Oxygen content in Capillary blood by calculation
63
503
1.26
0.98
3.1
2.3
%
16.1
16.3
0.20
35
234
(3001729) Color of Synovial fluid
5
23
2.18
0.98
1.0
2.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
82
675
1.22
0.98
1.9
3.4
ratio
2.3
1.7
—
10
55
(3052851) Hemolysis interference index of Serum or Plasma
102
858
1.19
0.98
2.8
3.0
—
—
—
0
0
(3039000) Anion gap in Blood
64
513
1.25
0.97
4.6
7.8
mmol/l
11.7
11.0
0.63
55
460
(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum
0
30
0.00
0.97
0.0
1.0
—
2.6
—
0
22
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
68
549
1.24
0.97
1.1
1.1
—
—
—
0
0
(3022689) Creatine [Moles/volume] in Urine
15
92
1.63
0.97
1.6
1.5
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
64
514
1.25
0.96
4.6
7.8
mmol/l
105.3
105.2
0.07
55
461
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
13
77
1.69
0.95
1.2
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
13
77
1.69
0.95
1.2
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
13
77
1.69
0.95
1.2
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
13
77
1.69
0.95
1.2
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
68
551
1.24
0.94
3.8
3.1
mmol/l
2.5
2.6
0.15
48
368
(3047007) Chlamydophila sp Ab [Presence] in Serum
66
535
1.24
0.92
1.2
1.2
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
269
2439
1.11
0.91
3.8
4.1
%
0.1
0.2
0.89
67
583
(3018840) Calcitonin [Moles/volume] in Serum or Plasma
6
28
2.14
0.91
1.0
2.3
—
9.3
—
0
7
(4306422)
66
536
1.24
0.91
1.1
1.2
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
45
349
1.29
0.90
1.3
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
16
243
0.66
0.90
1.1
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
32
236
1.36
0.89
1.3
1.2
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
17
111
1.53
0.87
1.0
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
117
1353
0.86
0.87
1.4
1.4
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
84
704
1.20
0.86
1.9
3.4
mg/l
44.9
45.1
0.01
71
572
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
117
1352
0.86
0.86
1.4
1.4
—
—
—
0
0
(4034850)
108
926
1.17
0.86
11.9
7.8
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
54
432
1.25
0.86
2.2
1.6
iu/ml
30.2
20.8
—
5
18
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
61
746
0.81
0.85
1.5
1.6
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
21
145
1.45
0.84
1.1
1.2
u/l
133.7
281.4
1.20
21
130
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
84
706
1.19
0.84
1.9
3.4
mg/l
38.5
35.8
0.15
71
573
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
6
31
1.94
0.84
1.2
1.3
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
117
1346
0.86
0.82
1.4
1.4
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
32
240
1.34
0.82
1.3
1.2
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
32
240
1.34
0.82
1.4
1.4
e6/l
6916.4
64662.6
0.99
18
159
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
30
223
1.35
0.81
1.3
1.2
—
—
—
0
0
(3028772) Osteocalcin [Mass/volume] in Serum or Plasma
10
165
0.60
0.81
2.5
2.7
—
25.8
—
0
5
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
19
130
1.46
0.80
1.3
1.2
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
103
887
1.17
0.79
2.9
3.2
mmol/l
24.8
25.0
0.35
95
825
(3006922) Hepatitis E virus Ab [Presence] in Serum
28
207
1.36
0.79
1.0
1.1
—
—
—
0
0
(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum
0
25
0.00
0.79
0.0
1.0
—
0.1
—
0
14
(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
0
26
0.00
0.78
0.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
15
98
1.53
0.78
1.7
3.7
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
99
0.50
0.77
1.2
1.1
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
118
1347
0.87
0.76
1.4
1.4
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
28
0.00
0.76
0.0
2.8
—
—
—
0
0
(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum
0
28
0.00
0.76
0.0
1.0
—
6.7
—
0
20
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
10
59
1.70
0.75
1.0
1.4
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
202
1827
1.11
0.75
2.8
2.5
e9/l
77.4
71.3
1.62
153
1336
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
38
482
0.79
0.75
1.3
1.4
—
—
—
0
0
(3019897) Erythrocyte distribution width [Ratio] by Automated count
61
504
1.21
0.75
2.4
2.6
%
13.3
13.2
0.60
61
497
(3004616) Nuclear Ab [Presence] in Serum
56
459
1.22
0.74
1.4
1.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
9
54
1.67
0.74
1.8
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
32
245
1.31
0.73
2.9
4.8
mmol/l
7.3
6.9
0.29
26
201
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
16
108
1.48
0.73
1.3
1.2
—
—
—
0
0
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
5
25
2.00
0.72
1.8
1.4
—
1.7
—
0
16
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
12
76
1.58
0.71
1.3
2.2
e6/l
7345.0
33409.8
—
6
41
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
15
218
0.69
0.71
1.0
1.1
u/l
1.3
1.1
—
6
96
(3003181) Sodium [Moles/volume] in Urine
37
467
0.79
0.71
1.5
1.4
mmol/l
70.0
63.5
0.39
31
367
(3020356) Listeria sp identified in Specimen by Organism specific culture
5
26
1.92
0.70
1.0
1.2
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
83
711
1.17
0.70
2.2
2.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
186
1683
1.11
0.70
1.7
2.2
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
7
41
1.71
0.70
4.0
9.2
—
—
—
0
0
(3000012) Reticulocyte production index
9
142
0.63
0.69
2.9
1.5
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
713
6811
1.06
0.69
2.1
1.9
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
20
274
0.73
0.69
1.0
1.1
—
—
—
0
0
(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma
14
204
0.69
0.68
1.1
1.8
mg/l
7.4
3.3
0.86
14
192
(3045142) Bone marrow Pathology biopsy report
22
296
0.74
0.68
1.4
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
161
1.37
0.68
1.0
1.1
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
155
1392
1.12
0.68
1.6
1.6
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
105
920
1.15
0.67
1.3
1.2
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
31
240
1.29
0.67
1.0
1.1
—
—
—
0
0
(4027681)
16
226
0.71
0.66
1.3
1.2
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
5
94
0.53
0.66
15.0
6.0
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
126
1415
0.89
0.66
2.0
1.7
mg/l
4.1
3.0
0.95
101
985
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
5
28
1.79
0.66
1.0
1.2
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
956
9218
1.05
0.66
1.6
1.5
—
—
—
0
0
(3013166) Neutrophils/100 leukocytes in Synovial fluid
11
70
1.57
0.65
1.2
1.4
%
49.3
40.2
0.36
11
55
(3002179) Metamyelocytes/100 leukocytes in Blood
256
2365
1.09
0.65
3.6
3.9
%
0.4
0.6
0.66
55
466
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
21
154
1.37
0.65
1.2
1.4
—
677.3
—
0
11
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
25
189
1.33
0.64
1.0
1.1
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
20
270
0.74
0.64
1.8
1.2
u/ml
3.5
0.8
0.38
11
100
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
266
2465
1.09
0.63
4.2
3.4
mmol/l
1.2
1.2
0.32
236
2125
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
12
177
0.68
0.63
2.5
2.6
e6/l
1053.0
803.5
—
5
77
(21494755) Public health laboratory ask at order entry panel
309
3309
0.93
0.62
1.3
1.3
—
—
—
0
0
(3034426) Prothrombin time (PT)
17
121
1.41
0.62
1.1
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
112
993
1.13
0.62
1.8
1.8
—
—
—
0
0
(44806420)
8
49
1.63
0.62
2.5
2.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
716
6865
1.05
0.62
1.3
1.4
g/l
2.3
2.2
1.32
432
4135
(3044290) Cell count panel - Cerebral spinal fluid
58
685
0.84
0.61
1.3
1.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
8
50
1.60
0.61
1.0
1.0
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
27
346
0.78
0.61
1.3
1.5
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
30
235
1.28
0.61
1.0
1.1
u/ml
0.3
2.8
—
5
67
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
15
210
0.71
0.60
2.7
3.6
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
253
2345
1.08
0.60
1.4
1.3
u/ml
168.7
153.1
0.18
235
2158
(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis
0
20
0.00
0.60
0.0
5.9
—
—
—
0
0
(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma
0
21
0.00
0.60
0.0
1.2
—
161.3
—
0
13
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
22
0.00
0.59
0.0
1.9
—
—
—
0
0
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
23
0.00
0.58
0.0
1.1
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
232
2504
0.92
0.58
2.4
2.4
au/ml
18.5
23.5
—
7
170
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
121
1348
0.89
0.58
2.0
1.7
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
54
637
0.85
0.57
1.1
1.1
u/ml
1.2
1.0
0.14
19
257
(3044009) aPTT.lupus sensitive (LA screen)
6
35
1.72
0.57
1.0
1.2
—
—
—
0
0
(3013512) EKG study
848
8183
1.05
0.57
3.5
3.4
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1116
11489
0.96
0.57
3.0
2.6
—
—
—
0
0
(3030313) Adrenal Ab [Titer] in Serum
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
13
184
0.71
0.56
1.0
1.6
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
6
37
1.62
0.55
1.2
2.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
109
975
1.12
0.54
1.2
1.1
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
8
123
0.65
0.54
3.1
3.2
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
205
1896
1.09
0.53
1.4
1.4
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
766
7387
1.05
0.53
2.2
2.0
—
—
—
0
0
(3000492) Spirometry study
316
2972
1.07
0.53
1.5
1.4
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
55
470
1.17
0.52
1.3
1.4
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
6
97
0.62
0.52
2.5
2.7
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
79
696
1.14
0.51
1.2
1.4
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
24
188
1.28
0.51
1.0
1.1
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
41
1.46
0.50
1.2
1.3
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
109
982
1.11
0.50
1.2
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
72
632
1.14
0.49
3.3
3.1
mg/l
22.3
23.1
0.08
52
370
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
144
1317
1.10
0.49
1.2
1.3
miu/ml
195.4
239.9
0.88
66
663
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
14
101
1.39
0.49
1.1
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
14
101
1.39
0.49
1.1
1.6
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
58
669
0.86
0.49
1.1
1.1
u/ml
3.7
4.6
0.26
26
328
(3021879) Hepatitis B virus core Ab [Presence] in Serum
239
2554
0.93
0.49
1.5
1.4
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
15
110
1.37
0.48
1.8
1.9
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
7
109
0.64
0.48
1.4
1.1
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
103
927
1.11
0.48
2.8
2.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
7
46
1.52
0.48
1.0
1.1
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
27
217
1.25
0.48
1.4
1.4
e6/l
1293.4
3116.9
1.61
21
157
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
41
345
1.19
0.47
2.5
2.0
u/ml
36.4
394.7
0.46
41
315
(3011412) CD3 cells [#/volume] in Blood
24
300
0.80
0.47
2.1
2.2
e9/l
1.0
1.2
1.10
18
188
(3024980) IgG subclass 4 [Mass/volume] in Serum
60
522
1.15
0.47
1.1
1.6
g/l
0.5
0.7
1.06
48
382
(3023183) Ammonium ion [Moles/volume] in Plasma
51
438
1.17
0.47
2.6
2.8
umol/l
34.7
32.7
0.28
46
383
(3014599) Egg white IgE Ab [Units/volume] in Serum
29
236
1.23
0.46
1.0
1.0
u/ml
2.4
1.0
—
6
56
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
22
173
1.27
0.46
1.8
1.5
u/ml
23.7
18.9
—
6
36
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
5
81
0.62
0.45
1.2
1.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
82
0.61
0.45
4.6
3.1
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
116
1056
1.10
0.45
1.8
1.9
iu/l
4.5
4.4
0.05
43
399
(40760888) Immunoglobulin light chains.free panel - Serum
61
534
1.14
0.45
1.6
3.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
73
821
0.89
0.44
1.2
1.2
u/l
10.4
13.9
1.81
64
682
(3003740) Influenza virus B Ag [Presence] in Specimen
47
544
0.86
0.43
1.2
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
47
544
0.86
0.43
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
37
312
1.19
0.43
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
37
312
1.19
0.43
1.2
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
37
312
1.19
0.43
1.2
1.2
—
—
—
0
0
(3032700) Glomerular basement membrane Ab [Units/volume] in Serum
5
31
1.61
0.43
1.0
1.0
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
106
964
1.10
0.43
1.2
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
102
926
1.10
0.42
1.8
2.2
g/l
3.1
3.1
0.25
79
720
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
15
113
1.33
0.42
1.1
1.2
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
25
306
0.82
0.42
1.8
2.6
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
32
1.56
0.42
1.2
1.1
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
5
33
1.52
0.41
1.8
1.0
—
—
—
0
0
(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
83
748
1.11
0.40
1.9
2.1
g/l
0.1
0.0
0.52
76
686
(3026692) Albumin [Mass/volume] in Peritoneal fluid
8
60
1.33
0.40
1.3
1.6
g/l
15.9
13.4
—
8
50
(3028029) Mesothelial cells/100 leukocytes in Pleural fluid
0
18
0.00
0.40
0.0
1.2
—
19.1
—
0
11
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
107
979
1.10
0.39
1.3
1.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
7
101
0.69
0.39
1.0
1.3
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
7
103
0.68
0.39
9.6
1.6
—
—
—
0
0
(3023709) Somatotropin [Mass/volume] in Serum or Plasma
7
103
0.68
0.39
1.1
2.1
ug/l
0.4
1.2
—
7
95
(3039744) RNA polymerase III Ab [Units/volume] in Serum
5
35
1.43
0.39
1.0
1.1
—
4.7
—
0
5
(3004809) Band form neutrophils/100 leukocytes in Blood
47
409
1.15
0.39
2.6
2.9
%
1.6
1.5
0.04
38
316
(3021387) Prolactin [Units/volume] in Serum or Plasma
133
1437
0.92
0.39
1.4
1.7
mu/l
531.1
307.7
0.48
118
1270
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
61
541
1.13
0.39
1.2
1.3
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
18
142
1.27
0.38
1.2
1.2
g/l
0.3
0.3
1.16
12
116
(3011436) Histone Ab [Units/volume] in Serum
11
80
1.38
0.38
1.0
1.1
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
28
334
0.84
0.38
1.1
1.2
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
35
409
0.85
0.38
1.1
1.1
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
91
828
1.10
0.38
2.5
2.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
27
323
0.83
0.38
2.3
2.9
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
9
67
1.34
0.38
1.1
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
12
89
1.35
0.37
1.1
1.1
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
61
543
1.13
0.37
1.3
1.2
u/ml
5.3
2.8
0.28
19
166
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
22
179
1.23
0.37
1.0
1.3
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
10
72
1.39
0.36
1.2
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
244
2314
1.06
0.36
2.3
2.7
g/l
10.4
10.3
0.10
226
2117
(40759836) Histone Ab [Presence] in Serum by Immunoblot
36
309
1.17
0.36
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
36
309
1.17
0.36
1.2
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
414
4304
0.96
0.36
1.2
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
38
328
1.16
0.36
1.3
1.4
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
13
99
1.31
0.35
1.3
1.9
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
318
3041
1.05
0.35
1.8
1.8
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
36
310
1.16
0.35
1.2
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
148
1383
1.07
0.35
1.5
1.7
—
—
—
0
0
(44790048)
35
301
1.16
0.35
1.4
1.4
—
—
—
0
0
(44790047)
35
301
1.16
0.35
1.4
1.4
—
—
—
0
0
(44790049)
35
301
1.16
0.35
1.4
1.4
—
—
—
0
0
(44806118)
35
301
1.16
0.35
1.4
1.4
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
1400
14237
0.97
0.34
2.0
2.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
73
805
0.90
0.34
1.1
1.1
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
23
190
1.21
0.34
1.4
1.4
e6/l
8245.9
54879.7
1.06
13
108
(3015183) Erythrocyte sedimentation rate
14
178
0.79
0.34
1.1
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
68
614
1.11
0.34
1.4
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
478
4620
1.04
0.33
1.2
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
380
3655
1.04
0.33
1.3
1.4
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
105
970
1.08
0.33
1.8
2.2
g/l
3.7
3.7
0.20
79
701
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
36
414
0.87
0.33
4.8
4.5
u/ml
69.1
87.7
—
10
120
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
86
0.70
0.33
1.0
1.1
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
105
971
1.08
0.33
1.8
2.2
g/l
8.0
7.4
1.76
78
740
(3009542) Hematocrit [Volume Fraction] of Blood
2896
29143
0.97
0.32
14.7
12.9
%
39.0
39.2
0.51
2129
22049
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
218
2295
0.95
0.32
1.3
1.3
au/ml
43.2
40.5
—
9
92
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
38
434
0.87
0.32
1.0
1.0
u/ml
0.1
0.1
—
6
95
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
26
306
0.85
0.32
1.3
1.3
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
18
146
1.23
0.32
1.5
1.4
nmol/l
140.8
125.2
0.85
18
146
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
20
241
0.83
0.31
1.5
1.8
%
11.8
12.8
—
6
116
(3029075) Extractable nuclear Ab panel - Serum
14
110
1.27
0.31
1.0
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
28
239
1.17
0.31
3.1
2.8
%
51.2
56.3
0.47
20
148
(3024522) Salmonella sp identified in Specimen by Organism specific culture
36
411
0.87
0.31
1.5
1.4
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
14
175
0.80
0.30
1.4
1.8
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
7
99
0.71
0.30
2.6
2.3
—
151.4
—
0
14
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
50
558
0.89
0.30
1.0
1.1
u/ml
1.2
3.2
2.49
20
264
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
61
552
1.11
0.30
1.2
1.2
—
—
—
0
0
(4094501)
81
744
1.09
0.30
1.1
1.1
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
77
706
1.09
0.30
1.5
1.3
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
260
2488
1.05
0.30
1.2
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
331
3437
0.96
0.29
1.7
1.6
%
1.4
1.3
1.21
284
3039
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
36
409
0.88
0.29
1.5
1.4
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
12
152
0.79
0.29
1.1
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
68
621
1.10
0.29
1.4
1.5
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
104
969
1.08
0.28
1.8
2.2
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
27
232
1.17
0.28
1.5
1.4
g/l
31.9
34.5
0.39
22
208
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
136
1444
0.94
0.28
1.5
1.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
244
2337
1.05
0.28
1.5
1.7
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
36
407
0.88
0.28
1.5
1.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
76
700
1.09
0.27
1.3
1.2
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
195
2044
0.95
0.27
1.1
1.1
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
128
0.78
0.26
1.1
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
8
66
1.21
0.26
1.1
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
95
1.26
0.26
2.6
2.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
10
77
1.30
0.26
1.2
2.3
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
5
73
0.68
0.26
1.2
1.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
31
352
0.88
0.26
2.9
2.0
mg/l
18.5
22.7
—
7
93
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
172
1637
1.05
0.26
2.2
2.4
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
11
138
0.80
0.25
1.5
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
11
138
0.80
0.25
1.5
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
11
138
0.80
0.25
1.5
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
36
404
0.89
0.25
1.5
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
36
404
0.89
0.25
1.5
1.4
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
82
762
1.08
0.25
1.9
2.0
g/l
37.3
38.3
0.81
76
666
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
14
170
0.82
0.25
1.1
1.1
miu/ml
1436.2
1526.7
0.15
14
170
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
75
1.20
0.25
1.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
13
159
0.82
0.24
1.2
1.6
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
27
236
1.15
0.24
1.1
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
10
78
1.28
0.24
1.2
2.0
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
18
212
0.85
0.24
1.6
1.4
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
6
84
0.71
0.24
1.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
14
169
0.83
0.24
1.6
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
57
523
1.09
0.23
1.1
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
57
523
1.09
0.23
1.1
1.3
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
20
233
0.86
0.23
1.1
1.3
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
21
180
1.17
0.23
1.5
1.7
promille
1.2
1.1
0.07
14
138
(3019174) dRVVT (LA screen)
5
38
1.32
0.23
1.0
1.1
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
10
125
0.80
0.23
2.2
2.1
umol/l
48.1
55.2
—
10
96
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
95
893
1.07
0.22
1.8
2.2
g/l
10.0
10.1
0.13
80
760
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
153
1.18
0.22
1.2
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
20
172
1.16
0.22
1.0
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
36
399
0.90
0.21
1.3
1.5
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2095
21112
0.98
0.21
3.1
2.9
u/l
41.6
38.5
1.15
1979
19740
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
58
536
1.08
0.21
1.1
1.1
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
8
102
0.78
0.21
4.3
4.8
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
8
103
0.78
0.21
2.0
2.3
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
124
1179
1.05
0.21
2.5
2.0
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
8
105
0.76
0.21
1.0
1.3
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3045519) Venlafaxine [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
554.3
—
0
13
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
1.5
—
23.8
—
0
13
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
28
249
1.13
0.20
1.1
1.1
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
57
615
0.93
0.20
1.1
1.1
u/ml
0.5
1.5
1.13
11
141
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
23
261
0.88
0.20
7.4
6.5
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
526
5373
0.98
0.20
2.6
2.7
mmol/l
2.5
2.4
1.06
447
4700
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
111
0.81
0.20
1.0
1.1
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
126
1201
1.05
0.20
2.5
2.1
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
73
684
1.07
0.19
2.0
2.1
g/l
0.0
0.0
0.00
67
634
(3000764) Benzodiazepines [Presence] in Urine
125
1192
1.05
0.19
2.5
2.1
—
—
—
0
0
(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid
34
375
0.91
0.19
1.1
1.1
—
4.0
—
0
5
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
21
239
0.88
0.19
1.5
1.9
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
14
165
0.85
0.19
2.4
3.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
115
1095
1.05
0.19
2.6
2.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
26
291
0.89
0.19
1.3
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
23
203
1.13
0.19
1.0
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
16
137
1.17
0.18
1.2
1.5
—
—
—
0
0
(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection
11
132
0.83
0.18
1.5
1.5
iu/ml
—
643146.7
—
0
6
(3032057) Clostridioides difficile [Presence] in Stool
7
58
1.21
0.18
2.0
1.9
—
—
—
0
0
(3025577) Chromium [Mass/volume] in Blood
17
147
1.16
0.18
1.9
2.1
ug/l
2.1
3.3
0.66
17
126
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
70
658
1.07
0.18
3.2
3.7
%
57.1
57.1
0.00
70
658
(3027008) Opiates [Presence] in Urine
125
1196
1.05
0.18
2.5
1.9
—
—
—
0
0
(3015377) Calcium [Moles/volume] in Serum or Plasma
1035
10478
0.98
0.18
3.1
3.3
mmol/l
2.4
2.4
0.43
922
9173
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
31
341
0.91
0.17
1.1
1.1
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
66
0.76
0.17
1.8
1.8
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
8
68
1.18
0.16
1.1
1.1
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
100
1048
0.95
0.16
1.4
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
47
437
1.08
0.16
1.5
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
47
437
1.08
0.16
1.3
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
14
120
1.17
0.16
1.1
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
14
120
1.17
0.16
1.1
1.4
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
8
70
1.14
0.16
2.3
1.2
—
—
—
0
0
(4211845)
16
183
0.87
0.16
2.2
3.3
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
39
360
1.08
0.16
1.2
1.2
u/l
66.1
59.6
0.41
32
242
(40768443) Skin Pathology biopsy report
136
1413
0.96
0.16
1.2
1.2
—
—
—
0
0
(3017704) Immunofixation for Urine
13
111
1.17
0.15
1.0
1.7
—
—
—
0
0
(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood
35
380
0.92
0.15
1.1
1.1
—
1.4
—
0
6
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
77
0.78
0.15
1.0
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
55
516
1.07
0.15
1.3
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
20
224
0.89
0.15
1.0
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
36
332
1.09
0.15
1.5
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
16
140
1.14
0.15
1.2
1.5
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
17
192
0.88
0.14
1.1
1.2
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
7
88
0.80
0.14
1.7
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
24
217
1.11
0.14
1.6
1.4
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
24
217
1.11
0.14
1.6
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
24
217
1.11
0.14
1.6
1.4
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
48
512
0.94
0.14
1.7
1.3
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
17
150
1.13
0.14
1.1
1.3
—
—
—
0
0
(3026470) Cobalt [Mass/volume] in Blood
17
150
1.13
0.14
2.0
2.0
ug/l
3.2
3.9
0.15
17
137
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
87
831
1.05
0.14
1.9
2.2
g/l
0.4
0.6
0.60
78
728
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
73
694
1.05
0.14
2.0
2.1
g/l
0.0
0.0
0.49
67
636
(3023323) Follitropin [Units/volume] in Serum or Plasma
230
2360
0.97
0.14
1.3
1.3
iu/l
26.7
29.0
0.57
210
2059
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
72
757
0.95
0.14
1.2
1.1
u/ml
2.9
1.0
0.35
21
281
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
12
139
0.86
0.14
1.1
1.1
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
29
266
1.09
0.14
2.4
3.5
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
98
1021
0.96
0.13
1.6
1.6
iu/ml
22.6
0.3
0.47
19
202
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
39
418
0.93
0.13
1.6
1.4
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
12
138
0.87
0.13
1.4
1.5
—
—
—
0
0
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
12
138
0.87
0.13
1.0
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
17
190
0.89
0.13
1.5
1.4
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
15
169
0.89
0.12
2.4
3.2
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
11
127
0.87
0.12
1.3
1.1
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
47
498
0.94
0.12
1.1
1.1
u/ml
1.9
3.7
0.66
17
192
(3028707) Methadone [Presence] in Urine by Screen method
58
551
1.05
0.12
3.9
2.7
—
—
—
0
0
(40768441) Liver Pathology biopsy report
22
241
0.91
0.12
1.6
1.3
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
69
722
0.95
0.12
1.3
1.4
e6/l
22.6
29.5
0.22
55
541
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
69
722
0.95
0.12
1.4
1.4
e6/l
135.3
1352.5
2.24
56
578
(3025018) Bordetella pertussis Ab [Titer] in Serum
20
220
0.91
0.12
1.2
1.3
—
—
—
0
0
(3022145) Colonoscopy Study observation
364
3579
1.02
0.11
1.3
1.3
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
24
220
1.09
0.11
1.5
1.6
u/l
13.9
5.7
0.52
11
109
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
60
572
1.05
0.11
3.4
3.5
u/ml
87.8
791.0
0.89
53
521
(3016018) Differential panel - Cerebral spinal fluid
33
353
0.93
0.11
1.3
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
73
761
0.96
0.11
1.4
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
21
192
1.09
0.10
1.3
1.5
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
272
2768
0.98
0.10
3.9
3.5
u/ml
32.8
49.7
2.22
266
2671
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
5
45
1.11
0.09
1.0
1.2
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
5
46
1.09
0.09
1.0
1.5
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
46
1.09
0.09
1.0
1.4
—
—
—
0
0
(44806071)
6
57
1.05
0.08
1.2
1.1
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
49
469
1.05
0.08
1.4
1.6
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
59
613
0.96
0.08
1.1
1.2
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
297
3013
0.98
0.08
3.2
3.8
ug/l
16.7
37.1
0.55
223
2323
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
7
64
1.09
0.08
2.4
2.1
umol/l
12.5
17.1
—
7
64
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
25
234
1.07
0.08
1.1
1.2
—
—
—
0
0
(21494434) Karyotype in Bone marrow
18
195
0.92
0.08
1.1
1.2
—
—
—
0
0
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
26
244
1.07
0.08
1.1
1.1
iu/ml
20.9
8.7
—
5
65
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
7
67
1.04
0.08
1.3
1.2
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
74
0.81
0.07
1.0
1.1
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
12
108
1.11
0.07
3.7
2.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
7
85
0.82
0.07
1.0
1.1
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
17
157
1.08
0.07
1.1
1.3
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
90
877
1.03
0.07
1.3
1.3
u/ml
30.6
42.6
0.57
12
103
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
292
2884
1.01
0.07
2.4
2.2
u/l
63.4
37.3
0.38
241
2433
(3035880) pH of Pleural fluid
8
91
0.88
0.06
1.4
1.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
102
0.88
0.06
1.0
1.1
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
21
223
0.94
0.06
2.5
2.7
—
—
—
0
0
(4198724)
14
129
1.09
0.05
1.6
3.3
—
—
—
0
0
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
107
1051
1.02
0.05
1.0
1.1
u/ml
2.7
6.6
1.13
12
136
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
32
333
0.96
0.05
1.5
1.5
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
17
181
0.94
0.05
1.4
1.4
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
37
383
0.97
0.04
1.4
1.5
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
20
211
0.95
0.04
1.5
1.5
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
12
111
1.08
0.04
1.4
1.6
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
13
121
1.07
0.03
1.2
1.1
—
471.3
—
0
26
(21494814) CD8 cells/100 lymphocytes in Specimen
13
121
1.07
0.03
1.4
1.9
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
13
121
1.07
0.03
1.1
1.1
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
17
179
0.95
0.03
2.3
2.4
e9/l
0.1
0.4
0.70
17
173
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
47
480
0.98
0.02
1.1
1.1
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
18
172
1.05
0.02
3.4
3.7
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
11
103
1.07
0.02
1.6
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
18
173
1.04
0.01
1.5
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
124
1231
1.01
0.01
1.8
1.8
—
—
—
0
0
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
24
247
0.97
0.01
1.1
1.1
ratio
1.0
1.0
—
5
84
(36660697) Celiac disease serology panel - Serum
294
2949
1.00
0.01
1.2
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
53
537
0.99
0.01
1.1
1.0
u/ml
5.7
3.6
0.16
16
200
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
371
3701
1.00
0.01
1.4
1.4
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
200
2008
1.00
0.01
1.4
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
11
104
1.06
0.01
1.3
1.1
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
10
102
0.98
0.00
1.1
1.6
ug/l
10.0
8.5
—
10
102
(21491868) Cryoglobulin [Mass/volume] in Serum
12
122
0.98
0.00
1.2
1.2
g/l
—
0.4
—
0
9
(3028679) Herpes simplex virus Ab [Presence] in Serum
19
192
0.99
0.00
1.1
1.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
24
238
1.01
0.00
1.0
1.0
—
—
—
0
0
(4281824)
48
482
1.00
0.00
1.2
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
24
245
0.98
0.00
1.2
1.6
%
30.2
38.7
0.52
16
135
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
35
345
1.01
0.00
1.3
1.6
%
45.3
53.9
0.58
24
206
(1002224) Polysomnography panel
129
1295
1.00
0.00
1.0
1.1
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
11
111
0.99
0.00
1.5
1.5
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
11
111
0.99
0.00
1.5
1.5
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
28
279
1.00
0.00
1.3
1.5
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
29
289
1.00
0.00
1.6
1.4
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
46
464
0.99
0.00
1.2
1.2
—
—
—
0
0
(44813793)
29
286
1.01
0.00
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
26
263
0.99
0.00
1.2
1.2
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
96
957
1.00
0.00
3.2
3.4
u/ml
1099.7
497.1
0.37
80
812
(3006270) Folate [Moles/volume] in Blood
25
253
0.99
0.00
1.1
1.1
nmol/l
349.9
392.4
0.45
18
228
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
6
61
0.98
0.00
1.0
1.0
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40763791) Oxygen content in Venous blood by calculation
0
6
0.00
0.00
0.0
2.8
—
9.3
—
0
6
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3003593) Leptospira sp IgG Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3027696) Helicobacter pylori Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
1226.7
—
0
6
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.4
—
2.3
—
0
7
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.9
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
6
62
0.97
0.00
1.5
1.6
—
—
—
0
0
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
5
51
0.98
0.00
1.2
1.1
—
3.3
—
0
7
(3001409) Leptospira sp IgM Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3019298) Eosinophils/100 leukocytes in Peritoneal fluid
0
5
0.00
0.00
0.0
1.4
—
0.1
—
0
5
(3004268) Protein electrophoresis panel - Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
8
88
0.91
0.00
1.1
1.1
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.0
—
0.3
—
0
6
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
53
0.94
0.00
1.0
2.1
—
—
—
0
0
(3027859) Formaldehyde IgE Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
88.6
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.0
—
0.1
—
0
5
(3036180) Methadone [Presence] in Urine
0
6
0.00
0.00
0.0
2.2
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
8
80
1.00
0.00
1.3
1.1
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
5
55
0.91
0.00
1.0
2.8
—
—
—
0
0
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.0
—
0
5
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
8
0.00
0.00
0.0
2.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
26
260
1.00
0.00
1.6
1.5
—
—
—
0
0
(3013762) Body weight Measured
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(4133840)
6
63
0.95
0.00
1.0
1.1
—
—
—
0
0
(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay
8
86
0.93
0.00
1.3
1.1
u/ml
41.5
52.2
—
8
81
(3002079) Sodium [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.1
—
112.1
—
0
7
Mortality – FinRegistry
↥Association
Association between endpoint O15_GESTAT_OEDEM_PREINUR and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| O15_GESTAT_OEDEM_PREINUR | 0.781 [0.61, 1.0] | 0.049 |
| Birth year | 1.0 [0.99, 1.01] | 0.905 |
During the follow-up period (1.1.1998 — 31.12.2019), 76 out of 9505 females with O15_GESTAT_OEDEM_PREINUR died.
Males
No dataMortality risk
Mortality risk for people of age
years, who have O15_GESTAT_OEDEM_PREINUR.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.092% | No data |
| 5 | 0.551% | No data |
| 10 | 1.401% | No data |
| 15 | 2.607% | No data |
| 20 | 4.687% | No data |
Relationships between endpoints
↥Index endpoint: O15_GESTAT_OEDEM_PREINUR – Gestational [pregnancy-induced] oedema and proteinuria without hypertension
GWS hits: 2
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data